Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of TH-SC01 for Crohn's perianal fistula
CTR20243472Phase 3Active
- Sponsor
- T-Hone Biotech
- Start
- Mar 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease-associated perianal fistula (CPF) comparing TH-SC01 with Placebo (2 arms). Primary endpoint: Proportion of subjects achieving combined remission. Started Mar 2025; status: active.
02
Drugs
TH-SC01
03
Conditions
Crohn's disease-associated perianal fistula (CPF)
Beyond the preview
Go deeper on CTR20243472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243472.